• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IBSA FARMACEUTICI ITALIA SRL GELSYN KNEE INJECTION ; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IBSA FARMACEUTICI ITALIA SRL GELSYN KNEE INJECTION ; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Itching Sensation (1943); Pain (1994); Ambulation Difficulties (2544)
Event Date 12/14/2019
Event Type  Injury  
Event Description
Caller stated she received the injection in both knees 16.8 mg, 2ml, on (b)(6) 2019.Caller experienced worsened pain in both knees and itching in her left leg.The pain has caused difficulty ambulating.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELSYN KNEE INJECTION
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
IBSA FARMACEUTICI ITALIA SRL
MDR Report Key9596341
MDR Text Key175729267
Report NumberMW5092307
Device Sequence Number2
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 01/15/2020
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received01/15/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age76 YR
-
-